data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Novavax
(NASDAQ:NVAX)
$60.99
3.84[6.72%]
Last update: 1:35PM
Day High/Low55.7 - 62.4
52 Week High/Low34.88 - 277.8
Open / Close56.62 / -
Float / Outstanding77.9M / 78.1M
Vol / Avg.4.7M / 6.1M
Mkt Cap4.8B
P/E-
50d Avg. Price49.57
Div / Yield-
Payout Ratio-
EPS2.66
Total Float77.9M

Novavax (NASDAQ:NVAX), Quotes and News Summary

Novavax (NASDAQ: NVAX)

Day High/Low55.7 - 62.4
52 Week High/Low34.88 - 277.8
Open / Close56.62 / -
Float / Outstanding77.9M / 78.1M
Vol / Avg.4.7M / 6.1M
Mkt Cap4.8B
P/E-
50d Avg. Price49.57
Div / Yield-
Payout Ratio-
EPS2.66
Total Float77.9M
Benzinga - Sponsored
Benzinga - 1 hour ago
Benzinga - 4 hours ago
Benzinga - 4 days ago
Benzinga - 6 days ago
Benzinga - 6 days ago
Benzinga - Jun 28, 2022, 12:49PM
Benzinga - Jun 23, 2022, 4:02PM
Benzinga - Jun 23, 2022, 3:31PM
Benzinga - Jun 23, 2022, 2:48PM
Benzinga - Jun 23, 2022, 2:41PM
Benzinga - Jun 23, 2022, 10:10AM
Benzinga - Jun 23, 2022, 8:28AM
Benzinga - Jun 13, 2022, 11:06AM
Benzinga - Jun 13, 2022, 7:02AM
Benzinga - Jun 9, 2022, 3:01PM
Benzinga - Jun 9, 2022, 9:00AM
Benzinga - Jun 9, 2022, 8:59AM
Benzinga - Jun 9, 2022, 7:04AM
Benzinga - Jun 8, 2022, 2:57PM
Sector: Health Care.Industry: Biotechnology
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Novavax develops product candidates geared toward all age demographics of the general population.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-04
REV
Q1 2022Est.ActualSurprise
EPS2.6902.560 -0.1300
REV845.200M703.971M-141.229M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Novavax Questions & Answers

Q
How do I buy Novavax (NVAX) stock?
A

You can purchase shares of Novavax (NASDAQ: NVAX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Novavax's (NVAX) competitors?
Q
What is the target price for Novavax (NVAX) stock?
A

The latest price target for Novavax (NASDAQ: NVAX) was reported by Cantor Fitzgerald on Wednesday, June 8, 2022. The analyst firm set a price target for 168.00 expecting NVAX to rise to within 12 months (a possible 175.45% upside). 6 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Novavax (NVAX)?
A

The stock price for Novavax (NASDAQ: NVAX) is $60.99 last updated Today at July 5, 2022, 5:35 PM UTC.

Q
Does Novavax (NVAX) pay a dividend?
A

There are no upcoming dividends for Novavax.

Q
When is Novavax (NASDAQ:NVAX) reporting earnings?
A

Novavax’s Q2 earnings are confirmed for Thursday, August 4, 2022.

Q
Is Novavax (NVAX) going to split?
A

There is no upcoming split for Novavax.

Q
What sector and industry does Novavax (NVAX) operate in?
A

Novavax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.